(Q40661005)

22 September 2017

1 reference

title

A risk-benefit appraisal of drugs used in the management of premenstrual syndrome (English)

1 reference

22 September 2017

main subject

premenstrual syndrome

1 reference

J F Mortola

1

1 reference

22 September 2017

language of work or name

1 reference

1 February 1994

1 reference

22 September 2017

1 reference

22 September 2017

volume

10

1 reference

22 September 2017

issue

2

1 reference

22 September 2017

page(s)

160-169

1 reference

The Premenstrual Syndrome

22 September 2017

cites work

1 reference

12 December 2020

Lasting response to ovariectomy in severe intractable premenstrual syndrome

1 reference

12 December 2020

Further analyses of mortality in oral contraceptive users. Royal College of General Practitioners' Oral Contraception Study

1 reference

12 December 2020

Fluoxetine in the treatment of premenstrual syndrome

1 reference

12 December 2020

Endocrine Properties and Clinical Application of Danazol

1 reference

12 December 2020

The premenstrual syndrome. Effects of "medical ovariectomy"

1 reference

12 December 2020

Alteration of platelet serotonergic mechanisms and monoamine oxidase activity in premenstrual syndrome

1 reference

12 December 2020

Treatment of premenstrual syndrome with alprazolam: results of a double-blind, placebo-controlled, randomized crossover clinical trial

1 reference

12 December 2020

A prospective study of postmenopausal estrogen therapy and coronary heart disease

1 reference

12 December 2020

Progesterone and the premenstrual syndrome: a double blind crossover trial

1 reference

12 December 2020

Serotonin levels and platelet uptake during premenstrual tension

1 reference

12 December 2020

Sensory neuropathy with low-dose pyridoxine

1 reference

12 December 2020

Progesterone and the premenstrual syndrome: a double blind crossover trial

1 reference

12 December 2020

Treatment of premenstrual dysphoria with alprazolam. A controlled study.

1 reference

12 December 2020

Non-reversible and wide ranging voice changes after treatment with danazol

1 reference

12 December 2020

Cyclical variations in mood in normal women taking oral contraceptives

1 reference

12 December 2020

The reduction in risk of ovarian cancer associated with oral-contraceptive use

1 reference

12 December 2020

Vasomotor symptoms, serum estrogens, and gonadotropin levels in surgical menopause

1 reference

12 December 2020

The effect of a gonadotropin-releasing hormone agonist analog (nafarelin) on bone metabolism.

1 reference

12 December 2020

The use of prostaglandin inhibitors for the premenstrual syndrome

1 reference

12 December 2020

Binding and internalization of native gonadoliberin (GnRH) by anterior pituitary gonadotrophs of the rat. A quantitative autoradiographic study after cryoultramicrotomy

1 reference

12 December 2020

Vitamin B6 in the treatment of the premenstrual syndrome--a review.

1 reference

12 December 2020

Premenstrual syndromes: overview from a methodologic perspective

1 reference

12 December 2020

1 reference

12 December 2020

The use of an LHRH agonist, buserelin, in the long-term management of premenstrual syndromes.

1 reference

12 December 2020

FDA alert on evening primrose oil

1 reference

12 December 2020

Mood changes and menstrual symptoms with different gestagen/estrogen combinations. A double blind comparison with a placebo

1 reference

12 December 2020

Induced anovulation as treatment of premenstrual tension syndrome. A double-blind cross-over study with GnRH-agonist versus placebo

1 reference

12 December 2020

Effects of endogenous sex steroids on serum lipoproteins and postheparin plasma lipolytic enzymes

1 reference

12 December 2020

Danazol and urogenital sinus formation in pregnancy

1 reference

12 December 2020

Receptor-mediated internalization of fluorescent gonadotropin-releasing hormone by pituitary gonadotropes

1 reference

12 December 2020

Successful Treatment of Severe Premenstrual Syndrome by Combined Use of Gonadotropin-Releasing Hormone Agonist and Estrogen/Progestin*

1 reference

12 December 2020

Oral contraceptive use and breast cancer in young women in Sweden

1 reference

12 December 2020

The treatment of premenstrual symptoms with mefenamic acid

1 reference

12 December 2020

Treatment of premenstrual syndrome by spironolactone

1 reference

12 December 2020

Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome

1 reference

12 December 2020

Effect of seven low-dose combined oral contraceptive preparations on carbohydrate metabolism.

1 reference

12 December 2020

Ten years post-menopausal hormone replacement therapy--effect on lipoproteins

1 reference

12 December 2020

Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled, crossover study

1 reference

12 December 2020

Whole-blood serotonin in premenstrual syndrome

1 reference

12 December 2020

10.2165/00002018-199410020-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

22 September 2017

1026859438

0 references

1 reference